Evidence map›Paper›PMID 34639006›Full record

ArticleInternational journal of molecular sciences2021

RORα Suppresses Cancer-Associated Inflammation by Repressing Respiratory Complex I-Dependent ROS Generation.

Wei Mao, Gaofeng Xiong, Yuanyuan Wu, Chi Wang, Daret St Clair, Jia-Da Li, Ren Xu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Translational pediatrics · 2026
    Article
  3. Review
  4. Circadian clock and cancer.Military Medical Research · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Wei MaoMarkey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.ORCID 0000-0003-4741-4094
Gaofeng XiongMarkey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
Yuanyuan WuMarkey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
Chi WangMarkey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
Daret St ClairMarkey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
Jia-Da LiHunan International Scientific and Technological Cooperation Base of Animal Models for Human Disease, School of Life Sciences, Central South University, Changsha 410078, China.
Ren XuMarkey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.ORCID 0000-0002-3591-9522
University of Kentucky · USCentral South University · CN

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
University of Kentucky Center for Cancer MetabolismP20GM121327 · NIGMS · UNIVERSITY OF KENTUCKY · PI Jianhang Jia · 2017 to 2026
$25.0M
NCI NIH HHS P30 CA177558NIGMS NIH HHS P20 GM121327
6 · The paper itself

Abstract

Breast cancer development is associated with macrophage infiltration and differentiation in the tumor microenvironment. Our previous study highlights the crucial function of reactive oxygen species (ROS) in enhancing macrophage infiltration during the disruption of mammary tissue polarity. However, the regulation of ROS and ROS-associated macrophage infiltration in breast cancer has not been fully determined. Previous studies identified retinoid orphan nuclear receptor alpha (RORα) as a potential tumor suppressor in human breast cancer. In the present study, we showed that retinoid orphan nuclear receptor alpha (RORα) significantly decreased ROS levels and inhibited ROS-mediated cytokine expression in breast cancer cells. RORα expression in mammary epithelial cells inhibited macrophage infiltration by repressing ROS generation in the co-culture assay. Using gene co-expression and chromatin immunoprecipitation (ChIP) analyses, we identified complex I subunits NDUFS6 and NDUFA11 as RORα targets that mediated its function in suppressing superoxide generation in mitochondria. Notably, the expression of RORα in 4T1 cells significantly inhibited cancer metastasis, reduced macrophage accumulation, and enhanced M1-like macrophage differentiation in tumor tissue. In addition, reduced RORα expression in breast cancer tissue was associated with an increased incidence of cancer metastasis. These results provide additional insights into cancer-associated inflammation, and identify RORα as a potential target to suppress ROS-induced mammary tumor progression.

Indexed as

AnimalsBiomarkersCell RespirationCytokinesElectron Transport Complex IEnergy MetabolismGene Expression Regulation, NeoplasticHumansInflammationInflammation MediatorsNeoplasm MetastasisNeoplasmsNeoplasm StagingNuclear Receptor Subfamily 1, Group F, Member 1Reactive Oxygen SpeciesTumor-Associated MacrophagesBiomarkersCytokinesElectron Transport Complex IInflammation MediatorsNuclear Receptor Subfamily 1, Group F, Member 1Reactive Oxygen Speciesbreast cancercomplex Imacrophageorphan nuclear receptorreactive oxygen speciestumor microenvironment

Identifiers

PMID34639006
PMCPMC8509002
OpenAlexW3202699862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.